Mixed Salts of a Single-Entity Amphetamine Product 3.125 mg/1

Active Ingredient:: Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetam
Form:: CAPSULE, EXTENDED RELEASE
Brand:: Mixed Salts of a Single-Entity Amphetamine Product
Origin:: USA

Mixed Salts of a Single-Entity Amphetamine Product 3.125 mg/1 (Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetam CAPSULE, EXTENDED RELEASE) 3.125 mg/1

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine (Mixed Salts of a Single-Entity Amphetamine Product) 3.125 mg/1 extended-release capsules are a prescription medication used to treat ADHD and narcolepsy. This extended-release formulation provides controlled delivery of the active ingredients.

Strength

3.125 mg/1

Pack Size

100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0406-0805-01)

Manufacturer / TM Owner

SpecGx LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mixed Salts of a Single-Entity Amphetamine Product 3.125 mg/1 is primarily used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy. This medication helps improve focus, reduce impulsivity, and manage symptoms associated with these conditions. It is often prescribed when a patient requires a controlled release of the active ingredients throughout the day.

Side Effects

Common effects of Mixed Salts of a Single-Entity Amphetamine Product 3.125 mg/1 may include increased alertness, improved concentration, and reduced fatigue. Some individuals may experience side effects such as decreased appetite, insomnia, or mild gastrointestinal discomfort. The extended-release formulation is designed to minimize peaks and troughs in drug levels.

Precautions & Warnings

Handle Mixed Salts of a Single-Entity Amphetamine Product 3.125 mg/1 with care, as it is a controlled substance. Store it in a secure location to prevent misuse. Follow the prescribed dosage and administration instructions provided by your healthcare provider. Avoid sudden discontinuation without medical advice.

Avoid Interactions

Mixed Salts of a Single-Entity Amphetamine Product 3.125 mg/1 may interact with certain medications, including monoamine oxidase inhibitors (MAOIs), antidepressants, and other stimulants. Consuming alcohol while taking this medication is not recommended, as it may increase the risk of side effects. Always inform your healthcare provider of all medications you are taking.

Frequently Asked Questions

Mixed Salts of a Single-Entity Amphetamine Product 3.125 mg/1 is used to treat ADHD and narcolepsy by improving focus and managing symptoms.

Take Mixed Salts of a Single-Entity Amphetamine Product 3.125 mg/1 orally as directed by your healthcare provider, typically once daily in the morning.

Common side effects may include decreased appetite, insomnia, and mild gastrointestinal discomfort.

It is not recommended to consume alcohol while taking Mixed Salts of a Single-Entity Amphetamine Product 3.125 mg/1, as it may increase the risk of side effects.

Yes, Mixed Salts of a Single-Entity Amphetamine Product 3.125 mg/1 is a controlled substance and should be handled with care.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.